Search
Submit an article
Advanced targets in Biomedicine

2026 Vol. 2 №1

Back to the list Download the article
ENG
Сохранить XML для: JATS (вып.)
Musakhodjaeva D. A. Azizova Z. Sh. Isanbaeva L. M. Ishmuratova L. E.

Cytokine dysregulation in the pathogenesis of endometriosis, uterine fibroids and their combined forms

DOI
10.5922/ATB-2026-2-1-4
Pages
60-68
To cite
Musakhodjaeva D. A., Azizova Z. Sh., Isanbaeva L. M., Ishmuratova L. E. Cytokine dysregulation in the pathogenesis of endometriosis, uterine fibroids and their combined forms. Advanced targets in Biomedicine. 2026;2(1):60—68. https://doi.org/10.5922/ATB-2026-2-1-4
cytokines comorbidity angiogenesis dysregulation endometriosis uterine fibroids

Abstract

Endometriosis and uterine fibroids are hormone-dependent gynecological disorders whose pathogenesis is closely associated with chronic inflammation and impaired immune regulation.

Aim — to determine the pattern of changes in the serum cytokine profile in women with endometriosis, intramural uterine fibroids, and their combination.

Materials and methods. The study included 88 women of reproductive age divided into four groups. Serum levels of IL-2, IL-6, IL-8, and IL-10 were measured using enzyme-linked immunosorbent assay.

Results. A cytokine imbalance was identified in patients with endometriosis and uterine fibroids, characterized by decreased IL-2 levels and increased pro-inflammatory mediators. The most pronounced alterations were observed in the combined pathology, with maximal elevations of IL-6 and IL-8 accompanied by a marked reduction in IL-2 and IL-10.

Conclusion. The findings indicate a leading role of immunoinflammatory dysregulation in the pathogenesis of these conditions and highlight the clinical and pathogenetic relevance of assessing the serum cytokine profile.

Reference

  1. World Health Organization Endometriosis [Электронный ресурс], 2025, URL: https://www.who.int/news-room/fact-sheets/detail/endometriosis (дата обращения: 20.01.2026).
  2. Becker C. M., Bokor A., Heikinheimo O., Horne A., Jansen F., Kiesel L., et al. ESHRE guideline: endometriosis. Human Reproduction Open, 2022, 2, hoac009, DOI: 10.1093/hropen/hoac009.
  3. Ishikawa H., Goto Y., Hirooka C., Katayama E., Baba N., Kaneko M., et al. Role of inflammation and immune response in the pathogenesis of uterine fibroids: Including their negative impact on reproductive outcomes. Journal of Reproductive Immunology. 2024. 165, 104317, DOI: 10.1016/j.jri.2024.104317.
  4. Uimari, O., Nazri H., Tapmeier T. Endometriosis and uterine fibroids (leiomyomata): Comorbidity, Risks and Implications. Frontiers in Reproductive Health. 2021, 3, 750018, DOI: 10.3389/frph.2021.750018.
  5. Fiore A., Casalechi M., Sichenze L., Ferraroa C., Magnia B., Bellinghieri R., et al. Co-occurrence of endometriosis and uterine fibroids: A systematic review and meta-analysis. EClinicalMedicine. 2025. 89, 103510, DOI: 10.1016/j.eclinm.2025.103510.
  6. Terry K. L., Shafrir A., Laliberte A., Vitonis A. F., Garbutt K., DePari M., et al. Circulating inflam­matory biomarkers and endometriosis lesion characteristics in the WisE consortium. NPJ Wo­men’s Health. 2025, 3(1), 62, DOI: 10.1038/s44294-025-00110-x.
  7. Werdel R., Mabie A., Evans T. L., Coté R. D., Schlundt A., Doehrman P., et al. Serum levels of interleukins in endometriosis patients: A systematic review and meta-analysis. Journal of Minimally Invasive Gynecology. 2024, 31(5), 387—396.e11, DOI: 10.1016/j.jmig.2024.02.011.
  8. Boyman O., Sprent J. The role of interleukin-2 during homeostasis and activation of the immune system. Nature Reviews Immunology. 2012, 12(3), 180—190, DOI: 10.1038/nri3156.
  9. Spolski R., Li P., Leonard W. J. Biology and regulation of IL-2: from molecular mechanisms to human therapy. Nature Reviews Immunology. 2018, 18(10), 648—659, DOI: 10.1038/s41577-018-0046-y.
  10. Hunter C. A., Jones S. A. IL-6 as a keystone cytokine in health and disease. Nature Immunology. 2015, 16(5), 448—457, DOI: 10.1038/ni.3153.
  11. Tanaka T., Narazaki M., Kishimoto T. IL-6 in inflammation, immunity, and disease. Cold Spring Harbor Perspectives in Biology. 2014, 6(10), a016295, DOI: 10.1101/cshperspect. a016295.
  12. Коненков В. И., Шевченко А. В., Прокофьев В. Ф., Королева Е. Г., Тимофеева Ю. С., Айда­гулова С. В., и др. Системные факторы регуляции ангиогенеза при множественной миоме матки. Медицинская иммунология. 2025, 27(1), 57—68, DOI: 10.15789/1563-0625-SFR-2978.
  13. Couper K. N., Blount D. G., Riley E. M. IL-10: the master regulator of immunity to infection. Journal of Immunology. 2008, 180(9), 5771—5777, DOI: 10.4049/jimmunol.180.9.5771.
  14. Iyer S. S., Cheng G. Role of interleukin-10 transcriptional regulation in inflammation and autoimmune disease. Critical Reviews in Immunology. 2012, 32(1), 23—63, DOI: 10.1615/critrevimmunol.v32.i1.30.